{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:31:23Z","timestamp":1777890683896,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/mou.0b013e32833aa185","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T06:30:16Z","timestamp":1274164216000},"page":"313-317","source":"Crossref","is-referenced-by-count":18,"title":["New strategies for medical management of overactive bladder in children"],"prefix":"10.1097","volume":"20","author":[{"given":"Annette","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim W","family":"Th\u00fcroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/00365590802098367","article-title":"Treatment outcome of day-time urinary incontinence in children","volume":"42","author":"Hagstroem","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.urology.2007.01.049","article-title":"Initial trial of timed voiding is warranted for all children with daytime incontinence","volume":"69","author":"Allen","year":"2007","journal-title":"Urology"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MOU.0b013e32832c90d9","article-title":"Nonneurogenic voiding disorders: what's new?","volume":"19","author":"Glassberg","year":"2009","journal-title":"Curr Opin Urol"},{"issue":"5 Suppl 1","key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0090-4295(01)01633-8","article-title":"Central pathways controlling micturition and urinary continence","volume":"59","author":"Blok","year":"2002","journal-title":"Urology"},{"key":"R8-10-20210206","first-page":"227","article-title":"Neurophysiology of micturition and its modification in animal models of human diseases","author":"de Groat","year":"1993"},{"key":"R9-10-20210206","first-page":"33","article-title":"Autonomic inervation of the urinary bladder and urethra","author":"Lincoln","year":"1993"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01362-0","article-title":"International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacol Rev"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOU.0b013e32832ce8a4","article-title":"Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence","volume":"19","author":"Andersson","year":"2009","journal-title":"Curr Opin Urol"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.urology.2006.04.034","article-title":"Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin","volume":"68","author":"Van Arendonk","year":"2006","journal-title":"Urology"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(01)01569-2","article-title":"Preliminary study of the safety and efficacy of extended-release oxybutynin in children","volume":"59","author":"Youdim","year":"2002","journal-title":"Urology"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.juro.2009.06.058","article-title":"Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity","volume":"182","author":"Cartwright","year":"2009","journal-title":"J Urol"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1464-410X.2003.04085.x","article-title":"The use of tolterodine in children after oxybutynin failure","volume":"91","author":"Bolduc","year":"2003","journal-title":"BJU Int"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.urology.2004.09.036","article-title":"Should we switch over to tolterodine in every child with nonneurogenic daytime urinary incontinence in whom oxybutynin failed?","volume":"65","author":"Yucel","year":"2005","journal-title":"Urology"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-5347(05)64115-8","article-title":"Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence","volume":"169","author":"Reinberg","year":"2003","journal-title":"J Urol"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000152322.17542.63","article-title":"Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials","volume":"173","author":"Nijman","year":"2005","journal-title":"J Urol"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.eururo.2007.05.002","article-title":"Long-term tolerability of tolterodine extended release in children 5\u201311 years of age: results from a 12-month, open-label study","volume":"52","author":"Nijman","year":"2007","journal-title":"Eur Urol"},{"issue":"4 Suppl","key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.juro.2009.05.099","article-title":"Double anticholinergic therapy for refractory overactive bladder","volume":"182","author":"Bolduc","year":"2009","journal-title":"J Urol"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.sc.3100750","article-title":"Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia: a double-blind, placebo-controlled clinical trial","volume":"37","author":"Stohrer","year":"1999","journal-title":"Spinal Cord"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.eururo.2008.04.062","article-title":"Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial","volume":"55","author":"Marschall-Kehrel","year":"2009","journal-title":"Eur Urol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00148581-200507030-00002","article-title":"Contemporary and emerging drug treatments for urinary incontinence in children","volume":"7","author":"Humphreys","year":"2005","journal-title":"Paediatr Drugs"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14656566.7.10.1373","article-title":"Trospium chloride: the European experience","volume":"7","author":"Madersbacher","year":"2006","journal-title":"Expert Opin Pharmacother"},{"issue":"4 Suppl","key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.juro.2009.05.100","article-title":"Solifenacin for therapy resistant overactive bladder","volume":"182","author":"Hoebeke","year":"2009","journal-title":"J Urol"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"de Paiva","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Opinion in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOU.0b013e32833aa185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:47:43Z","timestamp":1740091663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042307-201007000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mou.0b013e32833aa185","relation":{},"ISSN":["0963-0643"],"issn-type":[{"value":"0963-0643","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}